Printer Friendly

NASA AND SUPRA MEDICAL CORP. ANNOUNCE ULTRASOUND JOINT EFFORT LEADING TO NON-INVASIVE BREAST CANCER DIAGNOSTICS

 CHADDS FORD, Pa., July 12 /PRNewswire/ -- Supra Medical Corp. (AMEX: SUM.EC) announced today that the two organizations are jointly developing advanced ultrasound instrumentation under the NASA/Industry Fellowship program.
 NASA will use the technology in a non-destructive evaluation of a new class of woven composite materials. Supra Medical will use the technology to extend its high resolution capability for the non-invasive examination of the breast. The collaboration began late last year at NASA's Langley Research Center, Hampton, Va.
 Dr. Thomas Yost, a Langley senior research physicist, said, "We are optimistic about the capability of the proposed instrumentation. It will allow us to locate and monitor small cracks throughout the life of some of the new aerospace materials."
 Evelyna Dyson-Cantwell, president of Supra Medical, also commented, adding, "We are developing techniques and ultrasound instrumentation which will allow safe, low cost, radiation free, painless, and verifiable diagnostic capabilities for detecting cancerous breast tumors at very early stages of growth."
 The Supra Medical president added that the firm's goal is to ultimately develop breast imaging technology which will serve all age groups of women from pre-adolescent to post-menopausal. The firm also intends to produce a final, marketable design which will have an enhanced utility to medical care professionals through the incorporation into the device of image pattern recognition technology.
 Langley has worked with Supra on prior technology development projects. Supra develops and markets specialty medical devices for the diagnosis, monitoring and continuing treatment of skin disorders including cancers, burns and other kinds of wounds.
 Under the fellowship program, Supra Medical has two employees working at Langley in the Nondestructive Evaluation Laboratory. Langley believes this program can speed the transfer of technology to commercial partners.
 For more information, please contact George Stasen, executive vice president of Supra, 800-388-6769.
 /delval/
 -0- 7/12/93
 /CONTACT: George Stasen, executive vice president of Supra Medical, 800-388-6769/
 (SUM)


CO: Supra Medical Corp.; NASA ST: Pennsylvania, Virginia IN: HEA SU: JVN

MJ-LJ -- PH011 -- 0341 07/12/93 10:42 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 12, 1993
Words:332
Previous Article:BREAST CANCER CLINICAL TRIALS OPEN IN PHILADELPHIA AREA; INFORMATION AVAILABLE VIA TOLL-FREE NUMBER
Next Article:DYNOKIDS/DYNOPALS BRING IN NEW SALES TEAM FROM OCEAN PACIFIC
Topics:


Related Articles
NASA PROJECT TO FURTHER ULTRASOUND DIAGNOSTIC FRONTIERS
SUPRA MEDICAL CORP. AND SONIX, INC. ANNOUNCE ULTRASOUND COLLABORATIVE EFFORT
MEDISCIENCE TECHNOLOGY CORP. AWARDED RESEARCH CONTRACT BY THE U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND
GENERAL ELECTRIC AND MEDISCIENCE TECHNOLOGY ENTER INTO A COLLABORATIVE RESEARCH AGREEMENT
GENERAL ELECTRIC AND MEDISCIENCE TECHNOLOGY ENTER INTO A COLLABORATIVE RESEARCH AGREEMENT
FISCHER IMAGING AND ACOUSTIC IMAGING SIGN ULTRASOUND DISTRIBUTION AGREEMENT
ATL Positioned for Expanded Growth
FDA Approves ATL's HDI(R) 3000 Ultrasound System for Breast Cancer Diagnosis
Waukesha Memorial Hospital Expands Diagnostic Capabilities With Revolutionary Medical Technology
NeoVision to present at Cruttenden Roth Healthcare Conference

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters